#physicalinactivity

Dr. Jamal A. Khan and Dr. Sharmin Yaqin, the visionary co-founders of Denvax Cancer Immunotherapy, have dedicated over 17 years to advancing dendritic cell therapy. Pioneering customized immunotherapy in India since 2004, their work has changed the lives of many, giving hope to cancer patients and empowering numerous individuals to become survivors. In their upcoming videos, Dr. Khan and Dr. Yaqin delve into inspiring patient stories, offering a rare, insightful look into the Denvax journey.

Dr. Jamal A. Khan and Dr. Sharmin Yaqin, the visionary co-founders of Denvax Cancer Immunotherapy, have dedicated over 17 years to advancing dendritic cell therapy. Pioneering customized immunotherapy in India since 2004, their work has changed the lives of many, giving hope to cancer patients and empowering numerous individuals to become survivors. In their upcoming videos, Dr. Khan and Dr. Yaqin delve into inspiring patient stories, offering a rare, insightful look into the Denvax journey. Discover how personalized cancer immunotherapy is making a profound difference for those in the fight against cancer.